Sign Up to like & get
recommendations!
1
Published in 2017 at "Current drug targets"
DOI: 10.2174/1389450117666160608120527
Abstract: The complete eradication of Chronic Myeloid Leukemia is still challenging even in the era of highly selective and potent BCR-ABL tyrosine kinase inhibitors (TKIs). The 'Achilles heel' of TKI-based CML therapy is the inability of…
read more here.
Keywords:
bcr;
pten;
abl hausp;
myeloid leukemia ... See more keywords